Multifunctional antibody responses from a primate Shigella outbreak inform vaccine design
Science Translational Medicine chose this article about vaccine design for Shigella as their featured article in September.
Over 60 years of life-saving research and humane animal care
Science Translational Medicine chose this article about vaccine design for Shigella as their featured article in September.
When illness strikes, white blood cells are the first cells on the scene. Much like a team of superheroes they each complete their specialized task, engulfing bacteria, controlling the immune response, and cleaning up dead or damaged cells. Leading the charge, is the macrophage, which literally translates to “big eater”. These white blood cells destroy …
Congenital heart defects are the most common type of birth defect in the United States and can result in heart failure early in life. Stem cell grafts offer potential as a treatment for cardiac defects, but both laboratory bench experiments and whole-animal studies are necessary for progress in this area. By testing cardiac treatments in …
A new investigational treatment for Parkinson’s disease is showing early promise in its first human clinical trial, thanks in part to foundational work at the University of Wisconsin–Madison and the Wisconsin National Primate Research Center (WNPRC).
Even babies born without the virus’s notable physical symptoms may experience sensory, attachment and anxiety issues, according to a new study.